IDEAS home Printed from https://ideas.repec.org/p/zbw/rpaebs/82023.html
   My bibliography  Save this paper

Einfluss der erfolgreichen Entwicklung von Covid-19-Impfstoffen und -Therapeutika auf die Finanzergebnisse pharmazeutischer Unternehmen

Author

Listed:
  • Hammerschmidt, Thomas

Abstract

Die Unternehmen BioNTech und Moderna haben mit den Covid-19-Impfstoffen zwischen 2020 und 2021 eine operative Gewinnmarge von 62% bzw. 72% erzielt, die somit weit über dem Industriedurchschnitt von ca. 25% liegt. Aus dieser hohen Gewinnmarge ergibt sich die Frage, welchen Einfluss die erfolgreiche Entwicklung von Covid-19-Arzneimitteln, d.h. Impfstoffen und/oder Therapeutika, auf Umsätze, Gewinne und Gewinnmargen innerhalb der pharmazeutischen Industrie insgesamt hat. [...]

Suggested Citation

  • Hammerschmidt, Thomas, 2023. "Einfluss der erfolgreichen Entwicklung von Covid-19-Impfstoffen und -Therapeutika auf die Finanzergebnisse pharmazeutischer Unternehmen," Rosenheim Papers in Applied Economics and Business Sciences 8/2023, Rosenheim Technical University of Applied Sciences.
    • Handle: RePEc:zbw:rpaebs:82023
    Note: Working Paper zum Vortrag auf der 15. Jahrestagung der Deutschen Gesellschaft für Gesundheitsökonomie Hannover, 13.-14.03.2023
    as

    Download full text from publisher

    File URL: https://www.econstor.eu/bitstream/10419/273368/1/1851809597.pdf
    Download Restriction: no
    ---><---

    More about this item

    Keywords

    Arzneimittel; Gewinne; Gewinnmargen; SARS-CoV-2; Umsätze;
    All these keywords.

    NEP fields

    This paper has been announced in the following NEP Reports:

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:zbw:rpaebs:82023. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: ZBW - Leibniz Information Centre for Economics (email available below). General contact details of provider: https://www.th-rosenheim.de/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.